Navarra Health Cluster holds its second General Assembly

Segunda Asamblea general NHC

Share this post

Navarra Health Cluster (NHC) held its second General Assembly on March 8 with the participation of its member entities at the Cima facilties. It was an opportunity to take stock of a busy 2023 and set ambitious goals for 2024.

The president of NHC and also corporate medical director of Cinfa, Alicia López de Ocáriz, opened the assembly by thanking the members for their time and commitment to the group’s activities. Thanks to this active participation, NHC has been able to consolidate and become a key interlocutor for the public authorities of Navarra in only a year and a half of operation. He also recalled that it was formed with 32 partners at the end of 2022 and already has 45 associates with more than 2.6 billion euros in annual turnover.

Laura Corcuera, managing director of NHC, presented the achievements of 2023, which “has been a year of construction”. True to its goal of being the unified voice of its member entities and representing their interests, NHC has met over the past year with the Ministry of Industry, Ecological and Digital Business Transition, the Ministry of Health, the Ministry of University, Innovation and Digital Transformation, as well as the Department of External Action.

The first results of the three working committees on Infrastructure, Talent and Innovation were also discussed; areas led, respectively, by Roberto Díez of Telum Therapeutics, David Zubeldía of Qube Pharma and Adrián Jiménez of Darwin Biomed. Linked to fundamental axes set in the 2023-2026 Strategic Plan, the importance of these working groups will increase in 2024 as NHC expects to have a strong impact on the competitiveness of the healthcare ecosystem with the contributions of its partners, and thus contribute to a more sustainable, digitized and attractive economy.

For 2024, NHC has set as a priority to be more proactive in order to continue with the lines of action opened in 2023: to boost the growth of the cluster by attracting new members and expanding the network; to develop the range of services provided with the organization of webinars, workshops and prospective events; to generate membership among associates and to achieve greater visibility for the cluster by boosting internal and external communication.

To mark the beginning of this new dynamic, the first edition of “Meet & Eat” was launched, a series of meetings in which four entities will be presented alternately each month to promote mutual knowledge and networking. This time, Cima, Vivet Therapeutics, the Public University of Navarra and Neuraptic IA opened the round of interventions.

Prior to the second General Assembly, the members of the associated entities were able to visit the Cima facilities and see first-hand the research platforms of Bioinformatics, Cytometry, Morphology and Genomics, among others. They also visited CIMA LAB Diagnostics, the comprehensive genetic and phenotypic diagnostic laboratory of the Clínica Universidad de Navarra.

More news